Trial Profile
An Open-label, Multicenter, Randomized, 3 Arm Study of S-1 Compared With S-1/CDDP, or S-1/CDDP Compared With 5-FU/CDDP in Patients With Advanced Gastric Cancer Previously Untreated With Chemotherapy for Advanced Disease.
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 05 Aug 2022
Price :
$35
*
At a glance
- Drugs Gimeracil/oteracil/tegafur (Primary) ; Cisplatin; Fluorouracil
- Indications Gastric cancer
- Focus Therapeutic Use
- Sponsors Taiho Pharmaceutical
- 05 Aug 2008 Actual start date changed from Jul 2005 to Mar 2002, according to Clinicaltrials.gov.
- 05 Aug 2008 Status changed from in progress to completed, as reported by ClinicalTrials.gov.
- 30 May 2008 Results presented at ASCO 2008.